Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.

Authors

Ioana R. Preston
Charles D. Burger
Sonja Bartolome
Zeenat Safdar
Michael Krowka
Namita Sood
Hubert J. Ford
Wejdan F. Battarjee
Murali M. Chakinala
Mardi Gomberg-Maitland, George Washington University
Nicholas S. Hill

Document Type

Journal Article

Publication Date

1-21-2020

Journal

The Journal of Heart and Lung Transplantation

DOI

10.1016/j.healun.2019.12.008

Comments

Online ahead of print

APA Citation

Preston, I. R., Burger, C. D., Bartolome, S., Safdar, Z., Krowka, M., Sood, N., Ford, H. J., Battarjee, W. F., Chakinala, M. M., Gomberg-Maitland, M., & Hill, N. S. (2020). Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.. The Journal of Heart and Lung Transplantation, (). http://dx.doi.org/10.1016/j.healun.2019.12.008

Peer Reviewed

1